Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach

Nursing and Health Professions

• Gastrointestinal Symptom 100%
• Diseases 100%
• Patient-Reported Outcome 33%
• Symptom Management 33%
• Constipation 33%
• Patient Experience 33%
• Data Warehouse 16%
• Transdermal Patch 16%
• Clinical Guideline 16%
• Malignant Neoplasm 16%
• Relaxation Training 16%
• Receptor 16%
• Advanced Cancer 16%
• Nausea and Vomiting 16%
• Nausea 16%
• Medical Decision Making 16%
• 17 Methylnaltrexone 16%
• Single Drug Dose 16%
• Dexamethasone 16%
• Electroacupuncture 16%
• Granisetron 16%
• Fosaprepitant 16%
• Diarrhea 16%
• Palonosetron 16%
• Serotonin 16%
• Aprepitant 16%
• Emetic Agent 16%
• Chemotherapy 16%
• Economic and Social Development 16%
• Education 16%

Medicine and Dentistry

• Gastrointestinal Distress 100%
• Diseases 100%
• Constipation 33%
• Patient Experience 33%
• Symptom Management 33%
• Patient-Reported Outcome 33%
• Malignant Neoplasm 16%
• Clinician 16%
• Advanced Cancer 16%
• Receptor Antagonist 16%
• Clinical Guideline 16%
• Diarrhea 16%
• Nausea and Vomiting 16%
• Single Drug Dose 16%
• Nausea 16%
• 17 Methylnaltrexone 16%
• Medical Decision Making 16%
• Aprepitant 16%
• Relaxation Training 16%
• Serotonin 16%
• Transdermal Patch 16%
• Emetic Agent 16%
• Fosaprepitant 16%
• Palonosetron 16%
• Electroacupuncture 16%
• Granisetron 16%
• Dexamethasone 16%
• Chemotherapy 16%
• Treatment Option 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Diseases 100%
• Gastrointestinal Symptom 100%
• Constipation 33%
• Methylnaltrexone 16%
• Granisetron 16%
• Electroacupuncture 16%
• Ginger 16%
• Advanced Cancer 16%
• Nausea 16%
• Serotonin 16%
• Receptor Antagonist 16%
• Nausea and Vomiting 16%
• Diarrhea 16%
• Dexamethasone 16%
• Aprepitant 16%
• Transdermal Patch 16%
• Emetic Agent 16%
• Fosaprepitant 16%
• Palonosetron 16%
• Chemotherapy Regimen 16%